Garvan Institute of Medical Research
64 papers found
ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors
The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
Precision Oncology in Surgery
Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors
Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic Cancer
BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma
Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer
∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling
Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense
Transient targeting of the pancreatic cancer stroma as a ‘fine-tuned’ anti-tumor and anti-metastatic therapy
A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts
Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice
Effective modulation of stromal signaling through ROCK inhibition: Is it all in the timing?
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
Lost in translation: returning germline genetic results in genome-scale cancer research.
SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer
Mitochondrial mutations and metabolic adaptation in pancreatic cancer
Whole-genome landscape of pancreatic neuroendocrine tumours
Hypermutation in pancreatic cancer
Missing publications? Search for publications with a matching author name.